Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans.
Sehwan ChunChan-Bum ChoiMin S KimJae-Yong NamTae Y LeeYoung-Tae LeeSungHoon KimSang-Bae HanSang-Cheol BaePublished in: Lupus (2022)
cells/kg in patients with LN.
Keyphrases
- bone marrow
- clinical trial
- induced apoptosis
- open label
- systemic lupus erythematosus
- cell cycle arrest
- double blind
- mesenchymal stem cells
- phase ii
- disease activity
- endoplasmic reticulum stress
- study protocol
- randomized controlled trial
- signaling pathway
- placebo controlled
- oxidative stress
- phase iii
- rheumatoid arthritis